Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Graham Corp
GHM
$1.32B
| $2.6M | ﹤0.01% |
119,019
+2,046
| +2% | +$44.2K |
|
|
CRON
2802
Cronos Group
CRON
$1.19B
| $2.6M | ﹤0.01% |
340,234
+10,804
| +3% | +$82.7K |
|
|
CBIO
2803
Crescent Biopharma
CBIO
$611M
| $2.59M | ﹤0.01% |
4,904
-139
| -3% | -$75.2K |
|
2804
Verrica Pharmaceuticals
VRCA
$86.9M
| $2.59M | ﹤0.01% |
16,324
+1,951
| +14% | +$288K |
|
2805
Commercial Vehicle Group
CVGI
$131M
| $2.59M | ﹤0.01% |
408,218
-21,242
| -5% | -$151K |
|
2806
United States Lime & Minerals
USLM
$3.43B
| $2.59M | ﹤0.01% |
143,295
+8,625
| +6% | +$152K |
|
|
BEST
2807
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $2.59M | ﹤0.01% |
+23,459
| New | +$2.57M |
|
|
BOCH
2808
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $2.59M | ﹤0.01% |
223,552
+1,910
| +0.9% | +$21.6K |
|
2809
Luxfer Holdings
LXFR
$457M
| $2.58M | ﹤0.01% |
139,685
-11,949
| -8% | -$206K |
|
2810
Flexsteel Industries
FLXS
$302M
| $2.58M | ﹤0.01% |
129,438
-24,270
| -16% | -$423K |
|
|
ITI
2811
DELISTED
Iteris, Inc.
ITI
| $2.58M | ﹤0.01% |
516,744
+49,384
| +11% | +$251K |
|
2812
Arq
ARQ
$101M
| $2.57M | ﹤0.01% |
245,230
-306
| -0.1% | -$3.66K |
|
|
UBX
2813
DELISTED
Unity Biotechnology
UBX
| $2.57M | ﹤0.01% |
35,635
+2,795
| +9% | +$197K |
|
|
HUYA
2814
Huya Inc
HUYA
$540M
| $2.56M | ﹤0.01% |
+144,034
| New | +$3.05M |
|
|
NVO
2815
Novo Nordisk
NVO
$201B
| $2.56M | ﹤0.01% |
88,502
+5,076
| +6% | +$141K |
|
|
SNCR
2816
DELISTED
Synchronoss Technologies
SNCR
| $2.56M | ﹤0.01% |
59,923
+1,767
| +3% | +$78.4K |
|
2817
Atlanta Braves Holdings Series A
BATRA
$3.66B
| $2.56M | ﹤0.01% |
86,321
+4,878
| +6% | +$139K |
|
2818
Pure Cycle
PCYO
$279M
| $2.56M | ﹤0.01% |
203,154
+10,493
| +5% | +$123K |
|
2819
Tiptree Inc
TIPT
$673M
| $2.55M | ﹤0.01% |
313,663
+8,868
| +3% | +$67.8K |
|
|
ELOX
2820
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $2.55M | ﹤0.01% |
8,654
+1,320
| +18% | +$266K |
|
|
SLCT
2821
DELISTED
Select Bancorp, Inc.
SLCT
| $2.55M | ﹤0.01% |
207,029
+2,206
| +1% | +$25.9K |
|
2822
Kinetik
KNTK
$4.14B
| $2.54M | ﹤0.01% |
88,974
+11,126
| +14% | +$256K |
|
|
CBMG
2823
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $2.54M | ﹤0.01% |
156,391
+5,601
| +4% | +$93.4K |
|
2824
Village Super Market
VLGEA
$630M
| $2.53M | ﹤0.01% |
109,133
-12,697
| -10% | -$329K |
|
2825
BGSF Inc
BGSF
$58.2M
| $2.52M | ﹤0.01% |
115,379
+3,164
| +3% | +$64.4K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.